Charcot Neuroarthropathy: A Major Cause of Morbidity in Diabetes

Poll

What role do bisphosphonates play in the management of a Charcot joint? Is arthrodesis preferred to osteotomy? What's the most common complication of Charcot foot? Take this mini-quiz.

 

Charcot neuroarthropathy is a major cause of morbidity for patients with diabetes mellitus.

Which statement about this neuropathy is false?

A. Bisphosphonates may expedite conversion of an active Charcot foot to a more stable, chronic stage.
B. Bisphosphonates significantly minimize bone resorption in patients with Charcot foot.
C. For medial column or more severe deformities, arthrodesis procedures are preferred to osteotomies.
D. The most common complication of Charcot foot is infection secondary to plantar ulcerations.
Related Videos
Laxmi Mehta, MD | Credit: American Heart Association
Reviewing 2023 with FDA Commissioner Robert M. Califf, MD
Erin Michos, MD | Credit: Johns Hopkins University
Natalie McCormick, PhD | Credit: American College of Rheumatology
Related Content
Anjali Dixit, MD, MPH | Credit: Stanford Medicine

GLP-1 Receptor Agonists Not Linked to Post-Op Respiratory Complications

April 25th 2024
Article
Default thumbnail for Diabetes Dialogue, featuring podcast logo and headshots of hosts.

Diabetes Dialogue: 2024 ACP Type 2 Diabetes Recommendations

April 19th 2024
Podcast
Carolyn J. Crandall, MD: Key Guideline Updates for Type 2 Diabetes

Carolyn J. Crandall, MD: Key Guideline Updates for Type 2 Diabetes

April 19th 2024
Article
Default thumbnail for Diabetes Dialogue, featuring podcast logo and headshots of hosts.

Diabetes Dialogue: STEP HFpEF DM and Fair Allocation of Incretin-Based Therapies

April 17th 2024
Podcast
Elena Christofides, MD | Credit: Endocrinology Associates

Insulin Glargine Biosimilar Demonstrates Bioequivalence to Originator for Type 2 Diabetes

April 13th 2024
Article
Manufacturing Costs for Diabetes Medicines Could Likely Be Lower | Image Credit: Harvard University

Manufacturing Costs for Diabetes Medicines Could Likely Be Lower, Study Finds

April 4th 2024
Article
© 2024 MJH Life Sciences

All rights reserved.